标题
Advances in clinical trial design: Weaving tomorrow’s TB treatments
作者
关键词
-
出版物
PLOS MEDICINE
Volume 17, Issue 2, Pages e1003059
出版商
Public Library of Science (PLoS)
发表日期
2020-02-28
DOI
10.1371/journal.pmed.1003059
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
- (2019) Patrick P. J. Phillips et al. PLOS MEDICINE
- Advances in clinical trial design for development of new TB treatments: A call for innovation
- (2019) Christian Lienhardt et al. PLOS MEDICINE
- A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
- (2019) Andrew J. Nunn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
- (2019) Natasha Strydom et al. PLOS MEDICINE
- Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs
- (2019) Daniel L. Clemens et al. PLoS One
- Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
- (2019) Kelly E. Dooley et al. PLOS MEDICINE
- Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
- (2019) Geraint Davies et al. PLOS MEDICINE
- Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness
- (2019) Piero L. Olliaro et al. PLOS MEDICINE
- Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
- (2019) Amita Gupta et al. PLOS MEDICINE
- Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
- (2019) Christian Lienhardt et al. PLOS MEDICINE
- Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
- (2019) Grania Brigden et al. PLOS MEDICINE
- The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
- (2019) Andrew Vernon et al. PLOS MEDICINE
- The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
- (2018) Elin M Svensson et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
- (2018) Narges Alipanah et al. PLOS MEDICINE
- State of the Art Review of HIV-TB coinfection in Special Populations
- (2018) Ethel D. Weld et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Challenges of TB and HIV co-treatment
- (2018) Jeffrey A. Tornheim et al. Current Opinion in HIV and AIDS
- A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
- (2018) Marjorie Z. Imperial et al. NATURE MEDICINE
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- Challenges in the clinical assessment of novel tuberculosis drugs
- (2016) Kelly E. Dooley et al. ADVANCED DRUG DELIVERY REVIEWS
- A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
- (2016) Patrick P. J. Phillips et al. BMC Medicine
- Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research
- (2016) Christian Lienhardt et al. CLINICAL INFECTIOUS DISEASES
- A Bayesian response-adaptive trial in tuberculosis: The endTB trial
- (2016) Matteo Cellamare et al. Clinical Trials
- Pragmatic Trials
- (2016) Ian Ford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis
- (2015) Derek J. Sloan et al. CLINICAL INFECTIOUS DISEASES
- Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
- (2015) Amita Gupta et al. CLINICAL INFECTIOUS DISEASES
- TB drug development: immunology at the table
- (2015) Carl Nathan et al. IMMUNOLOGICAL REVIEWS
- Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
- (2015) Sharon Nachman et al. LANCET INFECTIOUS DISEASES
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- A Simulation Study Evaluating Bio-Creep Risk in Serial Noninferiority Clinical Trials for Preservation of Effect
- (2015) K. Odem-Davis et al. Statistics in Biopharmaceutical Research
- Randomised controlled trials for Ebola: practical and ethical issues
- (2014) Clement Adebamowo et al. LANCET
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- Targeting Persisters for Tuberculosis Control
- (2012) Ying Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps
- (2012) J. S. Mathad et al. CLINICAL INFECTIOUS DISEASES
- Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis
- (2012) Patrick P. J. Phillips et al. JOURNAL OF INFECTIOUS DISEASES
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
- (2009) Marcus B Conde et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started